The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The US Food and Drug Administration granted marketing clearances for multiple infectious disease tests and a blood culture sample preparation system, among other devices.

Beckman Coulter Life Sciences , a global leader in laboratory automation and innovation, and an Operating Company of Danaher ...

Shares of Telesis Bio (NASDAQ:TBIO) surged ~110% in the premarket on Thursday after the nano-cap life sciences company ...

Shares of Telesis Bio were trading at double their closing price in the after-hours market following news the company entered a collaboration deal with Beckman Coulter Life Sciences. After the ...

A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.

Tests for SphingoTec's penKid biomarker of acute kidney injury will become available to central labs through Beckman Coulter's Access instruments.

"Joe is a proven leader with a strong track record of successfully growing businesses," Danaher VP Greg Milosevich said.

SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

DXC Technology Co. engages in the provision of technology consulting, outsourcing and support services. It operates through the Global Business Services (GBS) and Global Infrastructure Services ...